Tomofumi Nakatsukasa

Tomofumi Nakatsukasa

Auto-generated profile, based on publicly available information

Tomofumi Nakatsukasa

Department of Cardiology, The Sakakibara Heart Institute of Okayama , 2-5-1 Nakaicho, Kita-ku, Okayama, 700-0804

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2026 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
PBPatcharaporn Boottanun
Patcharaporn Boottanun
CNChiaki Nagai-Okatani
Chiaki Nagai-Okatani
KKKunio Kawanishi
Kunio Kawanishi
MBMasaki Baba
Masaki Baba
TNTomofumi Nakatsukasa
Tomofumi Nakatsukasa
AKAtsushi Kuno
Atsushi Kuno
Cardiac fibrosis with excessive extracellular matrix (ECM) accumulation is a hallmark of hypertensive heart failure. Characterizing glycan alterations within fibrotic ECM requires analytical strategies that integrate molecular detection with spatial and structural information. However, spatial glycomics approaches applicable to ECM-rich tissue regions remain limited. Here, we established an integrated lectin-based spatial glycomics workflow combining lectin microarray–based tissue glycome mapping, lectin histochemical staining, and low-vacuum scanning electron microscopy (LVSEM). This hierarchical analytical design enables lectin signal detection, spatial localization, and structural visualization within the same tissue section. Using this workflow, we mapped N- and O-glycan distribution in fibrotic regions of hypertensive heart failure rat hearts. Among 45 lectins, Maackia amurensis hemagglutinin (MAH)–reactive sialo-O-glycans were markedly increased in WFA-positive fibrotic regions compared with controls. Glycosidase pretreatment selectively reduced WFA and MAH signals, confirming their specificities for N- and O-glycans, respectively. High-resolution single-slide imaging combining lectin fluorescence histochemistry with LVSEM revealed distinct spatial partitioning of WFA and MAH signals within fibrotic ECM regions. Co-staining with ECM glycoproteins, including periostin, collagen VI α6 chain, cartilage intermediate layer protein 1, and thrombospondin 4, showed partial spatial overlap with lectin signals, suggesting that multiple ECM glycoproteins may contribute to the observed glycan signals. These results demonstrate a lectin-based spatial glycomics workflow integrating glycomic signal detection, spatial localization, and ultrastructural validation, establishing a lectin-based multimodal analytical framework for spatially resolved glycan partitioning in fibrotic tissues. Graphical abstract The alternative text for this image may have been generated using AI.

28 September 2026 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
RSRyo Shigeno
Ryo Shigeno
MMMasaki Miyasaka
Masaki Miyasaka
TMTakao Morikawa
Takao Morikawa
TNTomofumi Nakatsukasa
Tomofumi Nakatsukasa
AHArudo Hiraoka
Arudo Hiraoka
AHAtsushi Hirohata
Atsushi Hirohata

24 April 2026 in JACC: Case Reports
Verified
Journal Article
Open access
TSTakaaki Sato
Takaaki Sato
TMTakao Morikawa
Takao Morikawa
TNTomofumi Nakatsukasa
Tomofumi Nakatsukasa
TATeiji Akagi
Teiji Akagi
AHArudo Hiraoka
Arudo Hiraoka
AHAtsushi Hirohata
Atsushi Hirohata
Transseptal puncture is essential for transcatheter edge-to-edge repair (TEER) but is challenging in patients with previously implanted septal closure devices. A 79-year-old woman with prior transcatheter closure of both a patent foramen ovale and an atrial septal defect developed severe degenerative mitral regurgitation (MR). Transseptal access was considered difficult due to the 2 closure devices. However, chronic MR caused enlargement of the left atrium and interatrial septum, creating a narrow but feasible puncture zone. Using the VersaCross system, transseptal puncture was achieved, allowing TEER completion. Left atrial and septal enlargement from MR can create puncturable spaces despite prior septal closure devices. The VersaCross system enables controlled septal crossing, expanding the feasibility of TEER in anatomically complex patients. Chronic atrial remodeling secondary to severe MR may facilitate transseptal access after septal closure, and the VersaCross system can support safe puncture in challenging TEER cases.

24 August 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
KMKentaro Matsushita
Kentaro Matsushita
TNTomofumi Nakatsukasa
Tomofumi Nakatsukasa
TSTakaaki Sato
Takaaki Sato
AHAtsushi Hirohata
Atsushi Hirohata
Background: Fulminant myocarditis (FM) can rapidly progress to cardiogenic shock and cardiac arrest; however, the optimal timing of mechanical circulatory support (MCS) initiation remains uncertain, particularly regarding patients with rapidly progressive disease at risk of sudden haemodynamic deterioration. Case summary: A 57-year-old Asian man presented with chest pain following flu-like symptoms. On admission, he was hypotensive with elevated cardiac biomarkers and global left ventricular hypokinesia with a left ventricular ejection fraction of approximately 40%. Acute coronary syndrome was excluded by emergent coronary angiography. During evaluation in the cardiac catheterization laboratory, sustained ventricular tachycardia, rapidly worsening haemodynamic, and early signs of end-organ hypoperfusion indicated progressive cardiogenic shock with a high risk of further deterioration. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was therefore initiated based on these evolving clinical findings. Despite initial stabilization, the patient developed complete atrioventricular block followed by pulseless electrical activity, resulting in cardiac arrest within approximately 4 h of presentation. Combined support with VA-ECMO and Impella CP was established. Cardiac function gradually recovered, and the patient was successfully weaned from MCS. Endomyocardial biopsy confirmed lymphocytic myocarditis. Discussion: This case highlights the clinical importance of determining the optimal timing of MCS initiation in patients with suspected FM at high risk of rapid deterioration. Early support prior to further haemodynamic deterioration may stabilize circulation, facilitate diagnostic procedures, and provide a bridge to myocardial recovery.